Stay updated with breaking news from Elyra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reiterated their buy rating on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. A number of other research analysts have also commented on LYRA. Bank of America lowered their price target on […] ....
Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its price target trimmed by Bank of America from $12.00 to $11.00 in a research report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. LYRA has been the subject of several other reports. HC Wainwright reiterated a buy rating and issued […] ....